Previously unknown species of Aspergillus

Clinical Microbiology and Infection

Volumn 22, Issue 8, 2016, Pages 662-669

  Gautier, M ^a,b   Normand, A C ^b   Ranque, S ^a,b  

^a Aix Marseilles University   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Cryptic species; Environmental samples; Fungal identification; Human aspergillosis; MALDI TOF MS; Multi locus sequencing

Indexed keywords

FUNGAL DNA; ANTIFUNGAL AGENT;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ASPERGILLUS; CLINICAL LABORATORY; DNA SEQUENCE; FUNGUS IDENTIFICATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NOMENCLATURE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE; ANIMAL; ASPERGILLOSIS; CLASSIFICATION; DRUG EFFECTS; FUNGAL GENE; GENETICS; HEALTH SURVEY; HUMAN; ISOLATION AND PURIFICATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; DRUG RESISTANCE, FUNGAL; GENES, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; POPULATION SURVEILLANCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84991098059     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.05.013     Document Type: Review

References (67)

1. [1] Garber, G., An overview of fungal infections. Drugs 61:Suppl 1 (2001), 1–12.
2. [2] Kullberg, B.J., Oude Lashof, A.M.L., Epidemiology of opportunistic invasive mycoses. Eur J Med Res 7 (2002), 183–191.
3. [3] Walsh, T.J., Anaissie, E.J., Denning, D.W., Herbrecht, R., Kontoyiannis, D.P., Marr, K.A., et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46 (2008), 327–360.
4. [4] The Fungal Infection Trust. How common are fungal diseases? Fungal Research Trust 20th Anniversary meeting. London 18 June 2011, updated December 2012.
5. [5] Houbraken, J., de Vries, R.P., Samson, R.A., Modern taxonomy of biotechnologically important Aspergillus and Penicillium species. Adv Appl Microbiol 86 (2014), 199–249.
6. [6] Hubka, V., Nováková, A., Kolařík, M., Jurjević, Ž., Peterson, S.W., Revision of Aspergillus section Flavipedes: seven new species and proposal of section Jani sect. nov. Mycologia 107 (2015), 169–208.
7. [7] Norvell, L.L., Melbourne approves a new code. Mycotaxon 116 (2011), 481–490.
8. [8] McNeill, J., Barrie, F.F., Buck, W.R., Emoulin, V.D., Greuter, W., Hawksworth, D.L., (eds.) International code of nomenclature for algae, fungi, and plants (Melbourne Code), 2012, Koeltz Scientific Books, Königstein [Regnum vegetabile no. 154.].
9. [9] Samson, R.A., Visagie, C.M., Houbraken, J., Hong, S.-B., Hubka, V., Klaassen, C.H.W., et al. Phylogeny, identification and nomenclature of the genus Aspergillus. Stud Mycol 78 (2014), 141–173.
10. [10] de Hoog, G., Guarro, J., Gené, J., Figueras, M., Atlas of clinical fungi. 2nd ed., 2000, Centraalbureau voor Schimmelcultures, Utrecht.
11. [11] Balajee, S.A., Gribskov, J., Brandt, M., Ito, J., Fothergill, A., Marr, K.A., Mistaken identity: Neosartorya pseudofischeri and its anamorph masquerading as Aspergillus fumigatus. J Clin Microbiol 43 (2005), 5996–5999.
12. [12] Balajee, S.A., Nickle, D., Varga, J., Marr, K.A., Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping. Eukaryot Cell 5 (2006), 1705–1712.
13. [13] Balajee, S.A., Gribskov, J.L., Hanley, E., Nickle, D., Marr, K.A., Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell 4 (2005), 625–632.
14. [14] Nedel, W.L., Pasqualotto, A.C., Treatment of infections by cryptic Aspergillus species. Mycopathologia 178 (2014), 441–445.
15. [15] Schoch, C.L., Seifert, K.A., Huhndorf, S., Robert, V., Spouge, J.L., Levesque, C.A., et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc Natl Acad Sci U S A 109 (2012), 6241–6246.
16. [16] Irinyi, L., Serena, C., Garcia-Hermoso, D., Arabatzis, M., Desnos-Ollivier, M., Vu, D., et al. International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database—the quality controlled standard tool for routine identification of human and animal pathogenic fungi. Med Mycol 53 (2015), 313–337.
17. [17] Hubka, V., Kolarik, M., β-tubulin paralogue tubC is frequently misidentified as the benA gene in Aspergillus section Nigri taxonomy: primer specificity testing and taxonomic consequences. Persoonia 29 (2012), 1–10.
18. [18] Alanio, A., Beretti, J.-L., Dauphin, B., Mellado, E., Quesne, G., Lacroix, C., et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 17 (2011), 750–755.
19. [19] Cassagne, C., Ranque, S., Normand, A.-C., Fourquet, P., Thiebault, S., Planard, C., et al. Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. PloS One, 6, 2011, e28425.
20. [20] Normand, A.-C., Cassagne, C., Ranque, S., L'ollivier, C., Fourquet, P., Roesems, S., et al. Assessment of various parameters to improve MALDI-TOF MS reference spectra libraries constructed for the routine identification of filamentous fungi. BMC Microbiol, 13, 2013, 76.
21. [21] Becker, P.T., de Bel, A., Martiny, D., Ranque, S., Piarroux, R., Cassagne, C., et al. Identification of filamentous fungi isolates by MALDI-TOF mass spectrometry: clinical evaluation of an extended reference spectra library. Med Mycol 52 (2014), 826–834.
22. [22] Gautier, M., Ranque, S., Normand, A.-C., Becker, P., Packeu, A., Cassagne, C., et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: revolutionizing clinical laboratory diagnosis of mould infections. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 20 (2014), 1366–1371.
23. [23] Ranque, S., Normand, A.-C., Cassagne, C., Murat, J.-B., Bourgeois, N., Dalle, F., et al. MALDI-TOF mass spectrometry identification of filamentous fungi in the clinical laboratory. Mycoses 57 (2014), 135–140.
24. [24] Martiny, D., Cremagnani, P., Gaillard, A., Miendje Deyi, V.Y., Mascart, G., Ebraert, A., et al. Feasibility of matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) networking in university hospitals in Brussels. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 33 (2014), 745–754.
25. [25] Martiny, D., Cremagnani, P., Gaillard, A., Miendje Deyi, V.Y., Mascart, G., Ebraert, A., et al. Feasibility of matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) networking in university hospitals in Brussels. Eur J Clin Microbiol Infect Dis 33 (2014), 745–754.
26. [26] Accoceberry, I., Gabriel, F., Normand, A.-C., Djenad, F., Cassagne, C., L'Ollivier, C., et al. E-MALDI-TOF spectra-based routine mould identification. A French university hospital mycology laboratory experience, 2015.
27. [27] Schulthess, B., Ledermann, R., Mouttet, F., Zbinden, A., Bloemberg, G.V., Bottger, E.C., et al. Use of the Bruker MALDI biotyper for identification of molds in the clinical mycology laboratory. J Clin Microbiol 52 (2014), 2797–2803.
28. [28] Lau, A.F., Drake, S.K., Calhoun, L.B., Henderson, C.M., Zelazny, A.M., Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 51 (2013), 828–834.
29. [29] Balajee, S.A., Kano, R., Baddley, J.W., Moser, S.A., Marr, K.A., Alexander, B.D., et al. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 47 (2009), 3138–3141.
30. [30] Alastruey-Izquierdo, A., Mellado, E., Peláez, T., Pemán, J., Zapico, S., Alvarez, M., et al. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). Antimicrob Agents Chemother 57 (2013), 3380–3387.
31. [31] EUCAST. Clinical breakpoints n.d.
32. [32] Alastruey-Izquierdo, A., Alcazar-Fuoli, L., Cuenca-Estrella, M., Antifungal susceptibility profile of cryptic species of Aspergillus. Mycopathologia 178 (2014), 427–433.
33. [33] Verweij, P.E., Varga, J., Houbraken, J., Rijs, A.J.M.M., Verduynlunel, F.M., Blijlevens, N.M.A., et al. Emericella quadrilineata as cause of invasive aspergillosis. Emerg Infect Dis 14 (2008), 566–572.
34. [34] Howard, S.J., Multi-resistant aspergillosis due to cryptic species. Mycopathologia 178 (2014), 435–439.
35. [35] Gautier, M., Normand, A.-C., L'Ollivier, C., Cassagne, C., Reynaud-Gaubert, M., Dubus, J.-C., et al. Aspergillus tubingensis: a major filamentous fungus found in the airways of patients with lung disease. Med Mycol, 2016.
36. [36] Varga, J., Houbraken, J., Van Der Lee, H.A.L., Verweij, P.E., Samson, R.A., Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus. Eukaryot Cell 7 (2008), 630–638.
37. [37] Vinh, D.C., Shea, Y.R., Jones, P.A., Freeman, A.F., Zelazny, A., Holland, S.M., Chronic invasive aspergillosis caused by Aspergillus viridinutans. Emerg Infect Dis 15 (2009), 1292–1294.
38. [38] Vinh, D.C., Shea, Y.R., Sugui, J.A., Parrilla-Castellar, E.R., Freeman, A.F., Campbell, J.W., et al. Invasive aspergillosis due to Neosartorya udagawae. Clin Infect Dis Off Publ Infect Dis Soc Am 49 (2009), 102–111.
39. [39] Barrs, V.R., van Doorn, T.M., Houbraken, J., Kidd, S.E., Martin, P., Pinheiro, M.D., et al. Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs. PloS One, 8, 2013, e64871.
40. [40] Pavie, J., Lacroix, C., Hermoso, D.G., Robin, M., Ferry, C., Bergeron, A., et al. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. J Clin Microbiol 43 (2005), 4902–4904.
41. [41] Hubka, V., Kubatova, A., Mallatova, N., Sedlacek, P., Melichar, J., Skorepova, M., et al. Rare and new etiological agents revealed among 178 clinical Aspergillus strains obtained from Czech patients and characterized by molecular sequencing. Med Mycol Off Publ Int Soc Hum Anim Mycol 50 (2012), 601–610.
42. [42] Gupta, K., Gupta, P., Mathew, J.L., Bansal, A., Singh, G., Singh, M., et al. Fatal disseminated Aspergillus penicillioides infection in a three-month-old infant with suspected cystic fibrosis: autopsy case with review of literature. Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc, 2015 (epub ahead of print).
43. [43] Muraoka, S., Araki, Y., Izumi, T., Takeuchi, K., Okamoto, S., Wakabayashi, T., Cerebral infarction and subarachnoid hemorrhage caused by central nervous system Aspergillus infection. World Neurosurg, 2016 (epub ahead of print).
44. [44] Ellenbogen, J.R., Waqar, M., Cooke, R.P.D., Javadpour, M., Management of granulomatous cerebral aspergillosis in immunocompetent adult patients: a review. Br J Neurosurg, 2016, 1–6.
45. [45] Hall, W.A., Improving outcomes in cerebral aspergillosis. World Neurosurg 82 (2014), e139–e140.
46. [46] Damek, D.M., Lillehei, K.O., Kleinschmidt-DeMasters, B.K., Aspergillus terreus brain abscess mimicking tumor progression in a patient with treated glioblastoma multiforme. Clin Neuropathol 27 (2008), 400–407.
47. [47] Sutton, D.A., Wickes, B.L., Romanelli, A.M., Rinaldi, M.G., Thompson, E.H., Fothergill, A.W., et al. Cerebral aspergillosis caused by Aspergillus granulosus. J Clin Microbiol 47 (2009), 3386–3390.
48. [48] Houbraken, J., Due, M., Varga, J., Meijer, M., Frisvad, J.C., Samson, R.A., Polyphasic taxonomy of Aspergillus section Usti. Stud Mycol 59 (2007), 107–128.
49. [49] Verweij, P.E., Chowdhary, A., Melchers, W.J.G., Meis, J.F., Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?. Clin Infect Dis Off Publ Infect Dis Soc Am 62 (2016), 362–368.
50. [50] Hadrich, I., Makni, F., Neji, S., Cheikhrouhou, F., Bellaaj, H., Elloumi, M., et al. Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection. Med Mycol Off Publ Int Soc Hum Anim Mycol 50 (2012), 829–834.
51. [51] Alcazar-Fuoli, L., Mellado, E., Current status of antifungal resistance and its impact on clinical practice. Br J Haematol 166 (2014), 471–484 http://dx.doi.org/10.1111/bjh.12896.
52. [52] Lockhart, S.R., Zimbeck, A.J., Baddley, J.W., Marr, K.A., Andes, D.R., Walsh, T.J., et al. In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the transplant-associated infection surveillance network. Antimicrob Agents Chemother 55 (2011), 3944–3946 http://dx.doi.org/10.1128/AAC.00428-11.
53. [53] Van Der Linden, J.W.M., Warris, A., Verweij, P.E., Aspergillus species intrinsically resistant to antifungal agents. Med Mycol 49 (2011), S82–S89 http://dx.doi.org/10.3109/13693786.2010.499916.
54. [54] Escribano, P., Pelaez, T., Munoz, P., Bouza, E., Guinea, J., Is azole resistance in Aspergillus fumigatus a problem in spain?. Antimicrob Agents Chemother 57 (2013), 2815–2820 http://dx.doi.org/10.1128/AAC.02487-12.
55. [55] Peláez, T., Alvarez-Pérez, S., Mellado, E., Serrano, D., Valerio, M., Blanco, J.L., et al. Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia. J Med Microbiol 62 (2013), 474–478, 10.1099/jmm.0.044867-0.
56. [56] Posteraro, B., Mattei, R., Trivella, F., Maffei, A., Torre, A., De Carolis, E., et al. Uncommon Neosartorya udagawae fungus as a causative agent of severe corneal infection. J Clin Microbiol 49 (2011), 2357–2360, 10.1128/JCM.00134-11.
57. [57] Öz, Y., Özdemir, H.G., Gökbolat, E., Kiraz, N., Ilkit, M., Seyedmousavi, S., Time-kill kinetics and in vitro antifungal susceptibility of non-fumigatus Aspergillus species isolated from patients with ocular mycoses. Mycopathologia, 2015, 10.1007/s11046-015-9969-z.
58. [58] Balajee, S.A., Aspergillus terreus complex. Med Mycol 47 (2009), S42–S46, 10.1080/13693780802562092.
59. [59] Balajee, S.A., Baddley, J.W., Peterson, S.W., Nickle, D., Varga, J., Boey, A., et al. Aspergillus alabamensis, a new clinically relevant species in the section Terrei. Eukaryot Cell 8 (2009), 713–722, 10.1128/EC.00272-08.
60. [60] Kathuria, S., Sharma, C., Singh, P.K., Agarwal, P., Agarwal, K., Hagen, F., et al. Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing. PLozS One, 10, 2015, e0118997, 10.1371/journal.pone.0118997.
61. [61] Espinel-Ingroff, A., Diekema, D.J., Fothergill, A., Johnson, E., Pelaez, T., Pfaller, M.A., et al. Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 Document). J Clin Microbiol 48 (2010), 3251–3257, 10.1128/JCM.00536-10.
62. [62] Fuller, J., Schofield, A., Jiwa, S., Sand, C., Jansen, B., Rennie, R., Caspofungin etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration. J Clin Microbiol 48 (2010), 479–482, 10.1128/JCM.01677-09.
63. [63] Baddley, J.W., Marr, K.A., Andes, D.R., Walsh, T.J., Kauffman, C.A., Kontoyiannis, D.P., et al. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the transplant-associated infection surveillance network. J Clin Microbiol 47 (2009), 3271–3275, 10.1128/JCM.00854-09.
64. [64] Badali, H., Fakhim, H., Zarei, F., Nabili, M., Vaezi, A., Poorzad, N., et al. In vitro activities of five antifungal drugs against opportunistic agents of aspergillus Nigri complex. Mycopathologia, 2015, 10.1007/s11046-015-9968-0.
65. [65] Alastruey-Izquierdo, A., Cuesta, I., Houbraken, J., Cuenca-Estrella, M., Monzón, A., Rodriguez-Tudela, J.L., In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus. Med Mycol 48 (2010), 97–102, 10.3109/13693780902803040.
66. [66] Zotti, M., Machetti, M., Perotti, M., Barabino, G., Persi, A., A new species, Aspergillus persii, as an agent of onychomycosis. Med Mycol 48 (2010), 656–660, 10.3109/13693780903420641.
67. [67] Gheith, S., Saghrouni, F., Bannour, W., Ben Youssef, Y., Khelif, A., Normand, A.-C., et al. In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia. SpringerPlus, 3, 2014, 19, 10.1186/2193-1801-3-19.